Lozano ÁEÉ, García DK, Rodríguez RL, Milanés BL

Language: Spanish
References: 6
Page:
PDF size: 173.43 Kb.

ABSTRACT

Hyperparathyroidism is a disease caused by the increased secretion of the parathyroid hormone. A 46-year-old male patient went to the Endocrinology consultation at the People´s Committee Center of Medical Specialties, Quito, Ecuador, presenting initially an asymptomatic hypercalcemia with persisting calcium values, between 13.9 and 15.2 mg/dl. He also admitted having bone pain of different intensity since 6 months before, located in the forearms and the right leg. On the physical examination, the patient´s weight was 81 kg, his height was 178 cm, the body max index was 25.5 kg/m2 and his blood pressure was 140/80 mmHg. The related symptoms and signs, as well as complementary examinations, led to the clinical diagnosis of a primary hyperparathyroidism due to a parathyroid carcinoma, associated to a papillary thyroid carcinoma and a chronic renal failure. This case was considered appropriate for the report, due to the atypical manifestations and the absence of similar reports in the reviewed medical literature.

REFERENCES

1. Potts JP, Jüppner H .Trastornos de las glándulas paratiroides y homeostasis de calcio .En: Harrison. Principios de Medicina Interna. 20a ed. Nuevo México: Mcgraw-Hill Interamericana;2018[citado 01/04/2019].Disponible en: https://accessmedicina.mhmedical.com/content.aspx?bookid=2461§ionid=213019497

2. INE. Nódulo único y cáncer del tiroides En: Díaz Díaz O, Navarro Despaigne D. Manual de diagnóstico y tratamiento en Endocrinología y Metabolismo. La Habana: Ciencias Médicas; 2015. p.324-330.

3. Brance ML, Boscaffior A, Rodríguez ML, Miljevic J. Carcinoma De Paratiroides. Descripción de un caso clínico. Actual Osteol. 2015[citado 29/03/2019];11(1):82-89. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=1&sid=5da8390e-03ef-4649-8a24-e91dacd5daa1%40sessionmgr4008

4. Pulgar D, Jans J, D’Aguzan N, León A, Goñi I, González G, et al. Hiperparatiroidismo Primario: Manejo Quirúrgico. Rev Chil Cir. 2014[citado 29/03/2019];66(4):313-319. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=1&sid=308a485a-8d82-453f-a5a8-6484b6622652%40sessionmgr4007

5. López Gavilanez E, Guerrero Franco K, Segale Bajaña A, Solórzano Romero N, Navarro Chavez M. Cribado y caracterización bioquímica del hiperparatiroidismo primario en Guayaquil (Ecuador). Rev Osteoporos Metab Miner. 2017[citado 29/03/2019];9(2):82-88. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=1&sid=5428de11-c8e9-43ed-8867-707d093eba18%40sdc-v-sessmgr02

6. Cabané P, Carredano M, Rappoport D, Pineda P, Carreño L, Passalaqua W, et al. Paratirotoxicosis y tumor cervical palpable: caso clínico de cáncer de paratiroides. Rev Chil Cir. 2017[citado 29/03/2019];69(3):247-251. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=1&sid=299dcc78-d5e4-4637-9859-af7284788721%40sdc-v-sessmgr01